Conference Coverage: American Society of Hematology (ASH): Annual Meeting

Conference Coverage

CAR-T cell therapy rolls on in pediatric ALL

Key clinical point: CAR-T cell therapy continues to provide durable responses in early studies of children with refractory ALL. Major finding:...

Conference Coverage

VALOR: Baby step forward or misstep in AML?

Key clinical point: Vosaroxin plus cytarabine failed to significantly improve overall survival in relapsed or refractory AML, but may offer older...

Pages